Evaluation of the effect of carvedilol orodispersible tablets on ischemia-reperfusion injury and flap viability in rats: An in vivo study

dc.contributor.authorTokgonul, Serkan
dc.contributor.authorOzyilmaz, Emine Dilek
dc.contributor.authorComoglu, Tansel
dc.contributor.authorGurbuz, Manolya Mujgan
dc.contributor.authorTopal, Burcu Dogan
dc.contributor.authorKocak, Fatma Emel
dc.contributor.authorOzakpinar, Huelda Rifat
dc.date.accessioned2026-02-06T18:29:12Z
dc.date.issued2024
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractFlap surgery is an integral part of plastic surgery, and ischemia-reperfusion (I/R) injury significantly affects the viability of the flap. Carvedilol (CRV), a nonselective beta-blocker with alpha-1 blocking and antioxidant properties, and known for its potential in reducing I/R damage, was chosen as the active substance for our study. The aim of this study was to investigate the vasodilator and antioxidant effects of CRV on rat inferior epigastric artery skin flap using orally disintegrating tablets (ODTs). The optimized ODT formulation was subjected to in vivo experiments using Sprague-Dawley female rats (n = 24) divided into three groups: Group I (control, I/R), Group II (treatment, I/R + CRV), and Group III (treatment, I/R), I/R + CRV ODT). Reperfusion was then observed following the release of the microclamp from the pedicle, and the flap was then re-adapted to its original position. Control rats were given oral isotonic solution via gavage and were subjected to 8 h of ischemia and 12 h of reperfusion. Group II was given 2 mg/kg CRV oral tablets for 7 days before and after surgery. Group III was given 2 mg/kg/day CRV ODT for the same period. Biopsies were taken from the flap and histopathological and biochemical analyses including superoxide dismutase, glutathionenitric oxide, malondialdehyde, paraoxonase 1, total oxidant, and total antioxidant capacities were performed. This study demonstrates that CRV ODTs significantly increased flap viability by approximately 25% compared to the control group, highlighting their promising therapeutic potential. The vasodilator and antioxidant effects of carvedilol on rat inferior epigastric artery skin flap were investigated using orally disintegrating tablets (ODTs). ODT formulations were developed and their in vitro properties were evaluated. The optimized formulation was subjected to in vivo experiments using Sprague-Dawley female rats.image
dc.description.sponsorshipNone Funding Source: Medline
dc.identifier.doi10.1002/ardp.202400618
dc.identifier.issn0365-6233
dc.identifier.issn1521-4184
dc.identifier.issue12
dc.identifier.orcid0000-0002-1791-3055
dc.identifier.orcid0009-0005-6221-7584
dc.identifier.orcid0000-0001-5549-3883
dc.identifier.pmid39367562
dc.identifier.scopus2-s2.0-85205679887
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1002/ardp.202400618
dc.identifier.urihttps://hdl.handle.net/11129/11324
dc.identifier.volume357
dc.identifier.wosWOS:001325958100001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofArchiv Der Pharmazie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectcarvedilol
dc.subjectflap viability
dc.subjectischemia-reperfusion injury
dc.subjectorodispersible tablets
dc.titleEvaluation of the effect of carvedilol orodispersible tablets on ischemia-reperfusion injury and flap viability in rats: An in vivo study
dc.typeArticle

Files